N-Acetyl-L-Leucine, granules for suspension
Phase 3 small_molecule active
Quick answer
N-Acetyl-L-Leucine, granules for suspension for CACNA1A Disorders is a Phase 3 program (small_molecule) at Intrabio Ireland Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Intrabio Ireland Limited
- Indication
- CACNA1A Disorders
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active